Skip to main content

Table 1 Summary of survey results

From: UK national clinical audit: management of pregnancies in women with HIV

Does your service have a dedicated HIV in pregnancy MDT?
  Yes 111 (99%)
  No 1 (1%)
Does this MDT include:
  An HIV physician 112 (100%)
  An obstetrician 111 (99%)
  A paediatrician 110 (98%)
  An HIV midwife 29 (26%)
  An HIV clinical nurse specialist 21 (19%)
Following a new HIV diagnosis during antenatal screening, how quickly would you expect a women to be seen in the HIV clinic?
  Same/next day 40 (36%)
  2 – 3 days 23 (21%)
  Within a week 29 (26%)
  1 - 2 weeks 19 (17%)
  Not answered 1 (1%)
Do you have a policy for the use of ART in pregnancy?
  Yes 109 (97%)
  No 2 (2%)
  No response 1 (1%)
Would you use raltegravir in a women presenting after 28 weeks gestation with a VL > 100,000 copies/mL?
  Use routinely 56 (50%)
  May use 43 (38%)
  No policy/has not arisen 11 (10%)
  Would not use 1 (1%)
  Not sure 1 (1%)
What arrangement do you have in place for urgent HIV testing for women presenting in labour, with ruptured membranes of requiring delivery with no result?
  Arrangement for urgent lab test 95 (85%)
  Point of care testing in all delivery units 15 (13%)
  Urgent lab test not available 1 (1%)
  Not sure 1 (1%)
Have you experienced problems with urgent HIV testing?
  Problems experienced 10 (9%)
  Provided without problems 40 (36%)
  Need not arisen 55 (49%)
How long does it take to obtain an urgent HIV laboratory test result?
  >2 h in working hours 21 (19%)
  >2 h outside of working hours 56 (50%)
Do you have a policy on mode of delivery in HIV?
  Yes 107 (96%)
  No 2 (2%)
  Not sure/not answered 3 (3%)
What mode of delivery would you recommend for those on ART with a VL <50 copies/mL at >36 weeks, and no relevant obstetric factors?
  Planned vaginal delivery 95 (85%)
  Maternal choice 9 (8%)
  Pre-labour caesarean section 3 (3%)
  Other/not answered 5 (5%)
  1. MDT multidisciplinary team, ART antiretroviral therapy